CA2216700C - Compositions pharmaceutiques a effet synergique a base d'acetonide de triamcinolone et de halcinonide - Google Patents

Compositions pharmaceutiques a effet synergique a base d'acetonide de triamcinolone et de halcinonide Download PDF

Info

Publication number
CA2216700C
CA2216700C CA002216700A CA2216700A CA2216700C CA 2216700 C CA2216700 C CA 2216700C CA 002216700 A CA002216700 A CA 002216700A CA 2216700 A CA2216700 A CA 2216700A CA 2216700 C CA2216700 C CA 2216700C
Authority
CA
Canada
Prior art keywords
treatment
halcinonide
triamcinolone acetonide
psoriasis
figures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002216700A
Other languages
English (en)
Other versions
CA2216700A1 (fr
Inventor
Georges Chriki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PSORIAID SA
Original Assignee
Psorial LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psorial LLC filed Critical Psorial LLC
Priority claimed from PCT/US1995/009544 external-priority patent/WO1996003132A1/fr
Publication of CA2216700A1 publication Critical patent/CA2216700A1/fr
Application granted granted Critical
Publication of CA2216700C publication Critical patent/CA2216700C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Une composition pharmaceutique est constituée d'une association synergique contenant, comme principes actifs, au moins environ 0,01 % en poids d'acétonide de triamcinolone et au moins environ 0,01 % en poids de halcinonide, en association avec un excipient pharmaceutiquement acceptable.
CA002216700A 1995-07-27 1995-07-27 Compositions pharmaceutiques a effet synergique a base d'acetonide de triamcinolone et de halcinonide Expired - Fee Related CA2216700C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/009544 WO1996003132A1 (fr) 1994-07-28 1995-07-27 Compositions pharmaceutiques a effet synergique a base d'acetonide de triamcinolone et de halcinonide

Publications (2)

Publication Number Publication Date
CA2216700A1 CA2216700A1 (fr) 1996-02-08
CA2216700C true CA2216700C (fr) 2002-09-17

Family

ID=22249542

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002216700A Expired - Fee Related CA2216700C (fr) 1995-07-27 1995-07-27 Compositions pharmaceutiques a effet synergique a base d'acetonide de triamcinolone et de halcinonide

Country Status (3)

Country Link
CA (1) CA2216700C (fr)
DE (1) DE69506288T2 (fr)
DK (1) DK0840613T3 (fr)

Also Published As

Publication number Publication date
DE69506288T2 (de) 1999-06-24
CA2216700A1 (fr) 1996-02-08
DK0840613T3 (da) 2000-08-28
DE69506288D1 (de) 1999-01-07

Similar Documents

Publication Publication Date Title
US5063060A (en) Compositions and method for treating painful, inflammatory or allergic disorders
JP2008502659A (ja) 乾癬の治療のための、クロベタゾールプロピオネートとカルシトリオールとを含む製薬組成物の使用
EP0840613B1 (fr) Compositions pharmaceutiques a effet synergique a base d'acetonide de triamcinolone et de halcinonide
CA2408541C (fr) Traitement contre l'eczema et/ou le psoriasis
US6613800B1 (en) Method and compositions for treating psoriasis, eczema, seborrhea and arthritis
EP0908183A1 (fr) Déhydroépiandrostérone ou ses dérivés pour augmenter la quantité d'acide hyaluronique dans la peau
AU2001260833A1 (en) Treating eczema and/or psoriasis
US8586064B2 (en) Treating eczema and/or psoriasis
JP2005139210A (ja) 乾癬治療
US4119713A (en) Analgesic and anti-inflammatory composition
Harper Topical corticosteroids for skin disorders in infants and children
US20050152993A1 (en) Composition for and method of treatment for skin ailments
CA2216700C (fr) Compositions pharmaceutiques a effet synergique a base d'acetonide de triamcinolone et de halcinonide
GB2079151A (en) Medication for relief of intra-articular and intra-muscular discomfort
EP0916341A2 (fr) Compositions pharmaceutiques à effet synergique à base d'acétonide de triamcinolone et de halcinonide
JPH03227921A (ja) ケロイド治療剤
JPH06199672A (ja) 活性成分としてクロラムフェニコール、ゲンタマイシンおよびナイスタチンを含有する、炎症性皮膚疾患の局所治療のための配合製剤
US20040204492A1 (en) Topical composition and method for treating seborrheic dermatitis
AU2011269256B2 (en) Agent for the treatment of skin conditions
WO1992003142A1 (fr) Composition destinee au traitement topique du psoriasis
JP2024048695A (ja) 皮膚炎治療用の外用組成物
WO1994005301A1 (fr) Compositions destinees au traitement de la dermite, contenant du soufre, de l'acide salicylique et du dimethylsulfone
CA2121783A1 (fr) Compositions pharmaceutiques antisporiasiques et procede d'obtention
NZ522434A (en) Treating eczema and/or psoriasis

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130729